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Table 1. Serum Lipid Levels (mgldl) in the Diierent Rabbit Groups (n = 70) 
Cholesterol Triglycerides WDL Cholesterol 
Group Before Diet 10 Weeks 20 Weeks Before Diet 10 Weeks 20 Weeks Before Diet 10 Weeks 20 Weeks 
CF 38 ? 6 824 f 641 53 f 95 48 f 9 56 f 58 24-c 19 20 f 4 32 r?: 17 14 1?: 8 
F 164 f 126 983 + 348 38 + 18 129 f 38 115 A IO0 117 2 72 45 f 13 332 11 16 2 7 
cv 43 * 14 921 -c 585 47 f 33 84 f 42 51 +42 34 + 21 21 + 8 28 L 24 16 + 10 
V 74 + 20 1,049 + 333 233 f 127 161 r 55 130 + 91 111 268 46+ 40 48 z? 24 14 f 1 
Cl0 59 f 14 1,010 = 486 702 31 128 f 243 28 + 7 33 I- 19 
FV 120297 1.057 f 351 138 f 70 124 + 35 50 ? 36 66 f 24 34 2 9 36 + 16 12 2 6 
c20 128 + 137 1,388 rt 649 1,748 f 986 231 f 186 139 2 108 341 2 271 24 + 8 33 + 14 13 + 8 
Cl0 and C20 = control groups fed high cholesterol diet for IO and 20 weeks, respectively; CF and CV = control groups for fish oil and verapamil, respectively; 
F = fish oil group; FV = combined fish oil and verapamil group; V = verapamil group. 
cholesterol diet (Ziegler Bros., Inc.) contained 3% soybean 
oil and 0.3% cholesterol by weight. After 10 weeks on the 
diet, one control group (ClO) was then killed. Control group 
c20 was fed a 0.3% cholesterol diet for another 10 weeks. 
The other five groups were switched to a normal diet for the 
last 10 weeks. In addition to the normal diet, group F 
received 2 ml/day of fish oil (Proto-Chol mix, Banner Gelatin 
Products Corp, E. R. Squibb and Sons) for an additional 10 
weeks. One milliliter of fish oil contained 1,000 mg of marine 
lipid concentrate (180 mg eicosapentaenoic acid [EPA] and 
120 mg docosahexaenoic acid [DHA]; 35% of the fatty acid 
was omega-3); vitamin E, 1 IIJ; cholesterol, 5.3 mg and no 
vitamin A or D. The fish oil was administered daily by 
intrabuccal gavage. Group V received verapamil in the 
drinking water (2 g/1,000 ml) with honey added to taste, and 
group FV received both fish oil and verapamil for an 
additional 10 weeks. The verapamil drinking water was 
changed three times a week to assure potency. Group CF 
(control for the fish oil group) received 2 ml/day of drinking 
water by gavage and group CV (control for the verapamil 
group) received the drinking water without gavage for an 
additional 10 weeks. All animal procedures were carried out 
according to the National Institutes of Health guidelines. 
Laboratory methods. Weight and food consumption of
the rabbits were measured at the beginning of the experiment 
and at 5 week intervals thereafter. All rabbits ate an average 
of 147 g of feed each day. After fasting 12 h, blood samples 
were obtained at the beginning ofthe experiment and at 5 
week intervals for calcium and lipid determinations. Total 
serum cholesterol and triglyceride levels were determined by
automated nzymatic methods (Enzymatic Cholesterol Re- 
agent, Trig-Gpo Reagent, Behring Diagnosis; Dacos Coulter 
Electronics, Inc.). High density lipoprotein (HDL) choles- 
terol concentrations were measured after precipitation f 
other lipoprotein classes with dextran and magnesium ions 
(Fluorescence Light Scattering Multistat III Plus, instrumen- 
tation laboratory microcentrifugal analyzer), 
1 1-Dehydro-thromboxane Bz (thromboxane A2metabo- 
lite) in EWUPS C20, F, V and FV was measured on plasma 
samples with the use of radioimmunoassay kits (Amersham). 
andin F-I alpha (pros 
in plasma samples wit 
say kits (Biotecx Labora 
of verapamil and norverapamil in groups F and FV were 
measured by kigh pressure liquid chromatography ( 
science Laboratories) at death. 
Determination of bleeding tim s performed by w 
ing the rabbit ear for 5 min in a no saline bath rnai~~~~ed 
at a temperature of 37°C. The ear then removed from the 
bath and a standard prick was made into 
macroscopically obvious vessels. The incised ear wa 
immediately replaced into the saline bath, which was 
agitated with a magnetic stirrer. The ble 
as the time required for blood flow in the incision to cease. 
Each result represents the mean of two determinations. 
Ls. Rabbits were kill. J by an intrave- 
of sodium pentobarbital, 30 mg/kg bod 
weight. The chest was opened and the aorta was dissecte 
from its origin at the aortic valve to 2 cm beyond the 
bifurcation of the internal iliac arteries. The pulmonary 
artery was dissected from its origin at the pulmonary valve 
to the hila beyond the bifurcation. The vasculature was 
opened longitudinally, pinned endothelial side up toa cork 
board and placed in a normal saline bath. The aorta and 
pulmonary artery were fixed in 10% formalin, stained with 
Sudan IV and photographed. The stained lesions of the aorta 
and pulmonary artery surface were estimated quantitatively 
by planimetry of the sudanophilia in the photographs. The 
planimetric determinations were performed without knowl- 
edge of other data and average values were calculated from 
two determinations. 
aIysls. Data were subjected to an analysis of 
hen appropriate, pairwise comparisons were 
made with use of the unnett or Student-Newrna~~ I test. 
Student’s paired t test was used to compare th eding 
time before and after dietary fish oil or verapamil supple- 
mentation. A log transformation was used for choleste 
triglyceride, HDL cholesterol, 1 I-dehydr~-thromboxa~e 
6-keto-prostaglandin F-l alpha and the ratio of 6-ketil 
prostaglandin F-l alpha to 1 1-dehydro-thromboxane Bz val- 
JACC Vol. 15. No. I 
January 1 :231-7 
versus %%, 86%, 93% and 95%; Q 
changes (20 weeks versus 
s. There were no si~~j~ca~ 
serum HDE cholesterol levels an e percent change in 
e 2. Average Bleeding Time (s) in the Seven Rabbit Groups 
Group Control 10 Weeks 20 Weeks 
CF 56 + 9 47 + 8* 68 t 14 
6 54 ? 22 52 2 14 86 2 2it 
CV 91 ? 16 44 + lot 6629 
V 96+ 18 64 r 21 46 + 18t 
Cl0 69 + 21 51 + 11* 
FV 62 + 19 58 r 15 102 f 49’ 
C20 75 + 13 52 + 19t 54 + 16t 
*p < 0.05 or tp < 0.01 compared with control values. Abbreviations as in 
Table I. 
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Table 3. 1 I-Dehydro-Thromboxane B2 (nglml) Levels in the Four Rabbit Groups 
Gr0lJp Before Diet 5 weeks 10 Weeks IS Weeks 20 Weeks 
c20 13s 2 II 2OO*88 163 ? 159 159 2 IO4 150 + 138 
F 43 2 24 215 ‘, 163 204 2 110 203 + 92 179 f 37 
V 102 + 49 139 f 76 111 * 53 126 f 74 
FV 84* 113 117 f 66 210 + 125 1% + 114 1992 100 
No statistical differences when compared with the control group at IO or 20 weeks. Abbreviations as in Table I. 
prostaglandin Hthromboxane BZratio (Table 5) in the three 
treated groups was lower than that in control group C20. The 
ratio in group V was lower than that in group F and FV at 20 
weeks. Serum calcium levels for all seven groups did not 
change throughout the 20 weeks. The average s rum calcium 
level before diet and at 10 weeks and 20 weeks was 13.4 f
0.7,13.7 + 0.7 and 13.2 + 0.5 mgldl, respectively. The levels 
of serum verapamil and norverapamil in groups V and FV 
were in the therapeutic range (Table 6). 
was a positive correlation betwce~ t 
the aorta and in the pulmonary artery 
6.72 + 0.41x, R = 0.52, r = 0.72, p < 
was no correlation between the percent of lesions in the 
aorta nd changes in cholesterol in all seven grou 
osphologic studies. Figure 2 shows the percent of total 
aortic and pulmonary artery surface area exhibiting sudano- 
philia for each of the seven groups. The percent of aorta 
stained in group F and group V was less than that in control 
groups CF, Cl0 and C20 (15 t 17 and 16 f 12% versus 40 f 
14,40 rt 15 and 57 + 22%; p < 0.05, p < 0.01, respectively). 
The percent of aorta stained in group FV was 26 +- 24%; 
however, there was no significant difference between this 
value and that of the control groups except group C20. In 
control group CF (with gavage), the percent of aorta stained 
was a little higher than that in group CV without gavage (40 
+ 14 versus 33 +25%, p = NS). The percent of pulmonary 
artery surface area stained in group F and V was less than 
that in the control groups CF and C20 (11 2 9 and 12 f 9 
versus 24 + 9 and 37 + 11%; p < 0.05, p < 0.01, respec- 
tively). There were no significant differences among roups 
FV, Cl0 and CV (17 -C 14,20 f 7,19 -C 14%, respectively). 
been demonstrated in several animal specie 
bits, chickens, rats, dogs, pigeons, onhuman prim 
human beings after withdrawal of cholesterol from 
as well as after the administrating of c 
,I 1). Regression has been characterize 
plaques, arrest of cell proliferation, decreased numbers of 
cells and necrotic foci, lessened concentrations of choles- 
terol esters, free cholesterol and elastin, decreased activity 
of certain acyl esterases and altered composition of gly- 
cosaminoglycans (12). When the F’asma cholesterol is low- 
ered below about 150 mgldl, lipic ; mobilized from lesions 
and regression gradually occurs. After a prolonged period of 
low plasma cbolestero!, cholesterol esters and foam cells 
disappear and crystalline cholesterol gradually dissolves, 
leading to true regression (13). 
The average serum cholesterol levels at 20 weeks for each 
group are plotted in Figure 3 versus the percent of aorta 
The present study attempted todetermine whether lipid 
covered by lesions. The higher mean cholesterol level in 
lesions induced by a high lipid diet regressed after rabbits 
group V than that of other groups (F, CF and CV; p < 0.05) 
were placed on 1) a normal diet (C); 2) a normal diet with fish 
may have countered tosome degree the beneficial effects of 
oil (F); 3) a normal diet with verapamil (V); and 4) a normal 
fish oii SO that the xtc.nt oflesions in group FV was greater 
diet with fish oil and verapamil (FV). After 10 weeks on a
than that in group F or V. Multiple linear egression a alysis 
high cholesterol diet, conversion toa normal diet for 10 more 
weeks (groups CF and CV) did not cause r gression f lipid 
‘Mle 4. 6-Keto-Prostaglandii F-l Alpha Levels (pglml) in the Seven Rabbit Groups 
Group Before Diet 5 Weeks IO Weeks 
CF 582 2 I15 760 x 330 889 t 581 
F 3,805 + 7.914 15.4.$3 c 16.355 26,971 r cv 13,676 975 f 305 
949 r 505 1,140 + 807 V 
19,510 +21,405 27,080 f Cl0 14,501 989 2 556 
918 r 333 1.871 f 
FV 
1,815 
3.567 f 9,145 11,884 r 13,755 f c20 20,997 16.933 8,127 + 
12,254 8,307 2 10,992 21,128 f 13,877 
Abbreviations as in Table 1. 
I5 Weeks 
572 + 130 
1,226 r 2,661 
630 f 129 
13.658 + 17,147 
852 +- 625 
27,721 + 10,496 
20 Weeks 
615 2 323 
? 11,307 15,592 
458 I 69 
241 + 258 
-t 10,127 16,068 
27,597 f 15,956 
6. Serurrp Ve~a~a~il Levels (&liter) in the Two 
t Groups 
Group Verapamil Norverapamil 
V 137 + 39 122 2 45 
FV 82 f 34 62 * 53 
Therapeutic range 1aoto6M1 
Abbreviations as in Table I. 
2 d/day of fish oil contains 3 
A. Some data suggest that  re 
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Serum cholesterol (mgldl) 
Figure 3. Average serum cholesterol at20 weeks versus the percent 
of aortic surface covered by lesions for five rabbit groups. Abbre- 
viations as in Figure 1. 
presumably because of its antiplatelet ffects. However, 
there were no significant differences in ll-dehydro- 
thromboxane B2at 10 or 20 weeks when compared with that 
of the control group. Some investigators (30-32) proposed 
that the antithrombotic action of EPA (10, -30, -50 m&g 
per day) may be partially related to its effects on platelet 
aggregability and prostacyelin generation bythe vessel wall; 
but the major mechanism remains u clear. We measured 
dketo-prostaglandin F-l alpha in plasma s a potential 
marker of endothelial prostacyclin production. Results 
showed that he prostaglandin Flthromboxane Bz ratio was 
lower in the treated groups as compared with the control 
group (C20); the values in the verapamil group were the 
lowest. One study (33) reported that rats fed sheep fat 
displayed the highest values for prostaglydin l%/thrombox- 
ane B, ratio, whereas rats fed tuna fish oil showed the 
lowest, which may be because ofthe synthesis of thrombox- 
ane As. Because thromboxane A3 lacks biologic activity 
compared with thromboxane A*, the ‘biologically relevant’ 
prostacyclinlthromboxane Bz ratio in the fish oil group may 
have been higher t an the measured value indicates. 
erogenic of MI oil. Recent data (34,35) 
showed that n-3 fatty acids may interfere in several ways 
with the atherosclerotic process. Fish oil may have an 
antiatheromatous effect by 1) increasing the formation of 
prostacyclin, thus making the endothelial surface tess throm- 
bogenic; 2) blocking the production of thromboxane, thus 
ailowing fewer or smaller platelet thrombi to form in the 
vessel wall; 3) reducing the amount of platelet-derived 
growth factor eleased, thus diminishing i timal hyperplasia 
and the accumulation of foam cells; and 4) reducing the level 
of leukotriene I&, thus decreasing the inflammatory e- 
sponse at the site of injury to the vessel wall. Reduced 
vasoconstriction a d enhanced relaxation may be mecha- 
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n = 70 
50 
0 20 40 60 80 1 
% Aorta covered by lesions 
Figure 4. Relation between percent of aorta and pulmonary artery 
(PA) covered by lesions inall 70 rabbits (r = 0.72, p < 0. 
6.72 t 0.41x). 
endotbel~~m-dependent relaxa ion 
fish oil prolonged it. The combined fish oil-verapamil (FV) 
group had a bleeding time similar to that of the fish oil group 
(F). The values of pro ~a~d~~ F and the ratio of prosta- 
glandin Flthzomboxane 2 at 20 weeks in verapamil groups 
were lower than those of the fish oil group. Additional 
studies may shed light on this uggestive antagonistic effect. 
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